LA JOLLA PHARMACEUTICAL CO (LJPC) Stock Analyst Ratings

NASDAQ:LJPC • US5034596040

6.22 USD
0 (0%)
Last: Aug 19, 2022, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to LJPC. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 6.35. This target is 2.16% above the current price.
  • LJPC was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about LJPC.
  • In the previous month the buy percentage consensus was at a similar level.
  • LJPC was analyzed by 6 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
LJPC Historical Analyst RatingsLJPC Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 6.226.296.356.356.54 - 1.16% 2.16% 2.16% 5.17%

Related screens

Find peers 30% below price target
LJPC Current Analyst RatingLJPC Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades

LA JOLLA PHARMACEUTICAL CO / LJPC FAQ

What is the average price target for LA JOLLA PHARMACEUTICAL CO (LJPC) stock?

6 analysts have analysed LJPC and the average price target is 6.35 USD. This implies a price increase of 2.16% is expected in the next year compared to the current price of 6.22.


How do analysts rate LA JOLLA PHARMACEUTICAL CO (LJPC)?

The consensus rating for LA JOLLA PHARMACEUTICAL CO (LJPC) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.


Can you provide the analyst count for LA JOLLA PHARMACEUTICAL CO stock?

The number of analysts covering LA JOLLA PHARMACEUTICAL CO (LJPC) is 6.